Conditions: Migraine Headache
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 933
Healthy volunteers: no

Brief summary:
A study to compare rizatriptan (MK0462) 5 mg by mouth (p.o.) and sumatriptan 50 mg p.o. for the acute treatment of a migraine attack.

Detailed description:

Arms:
arm 1: Rizatriptan arm 2: Sumatriptan arm 3: Placebo

Interventions: intervention 1: rizatriptan benzoate (MK0462) intervention 2: Comparator: sumatriptan intervention 3: Comparator: Placebo
Intervention descriptions: intervention 1: single dose 5 mg rizatriptan p.o. intervention 2: single dose 50 mg sumatriptan p.o. intervention 3: Placebo to rizatriptan or sumatriptan, single dose placebo tablet taken orally

Protocol document: